[HTML][HTML] Vasopressin–aquaporin-2 pathway: recent advances in understanding water balance disorders

M Ranieri, A Di Mise, G Tamma, G Valenti - F1000Research, 2019 - ncbi.nlm.nih.gov
The alteration of water balance and related disorders has emerged as being strictly linked to
the state of activation of the vasopressin–aquaporin-2 (vasopressin–AQP2) pathway. The …

Nephronophthisis-pathobiology and molecular pathogenesis of a rare kidney genetic disease

S Gupta, JE Ozimek-Kulik, JK Phillips - Genes, 2021 - mdpi.com
The exponential rise in our understanding of the aetiology and pathophysiology of genetic
cystic kidney diseases can be attributed to the identification of cystogenic genes over the last …

Astroglial modulation of hydromineral balance and cerebral edema

YF Wang, V Parpura - Frontiers in Molecular Neuroscience, 2018 - frontiersin.org
Maintenance of hydromineral balance (HB) is an essential condition for life activity at
cellular, tissue, organ and system levels. This activity has been considered as a function of …

Activation of Calcium-Sensing Receptor increases intracellular calcium and decreases cAMP and mTOR in PKD1 deficient cells

A Di Mise, G Tamma, M Ranieri, M Centrone… - Scientific reports, 2018 - nature.com
Clinical and fundamental research suggest that altered calcium and cAMP signaling might
be the most proximal events in ADPKD pathogenesis. Cells from ADPKD cysts have a …

Olive Leaf Extract (OLE) impaired vasopressin-induced aquaporin-2 trafficking through the activation of the calcium-sensing receptor

M Ranieri, A Di Mise, M Centrone, M D'Agostino… - Scientific reports, 2021 - nature.com
Vasopressin (AVP) increases water permeability in the renal collecting duct through the
regulation of aquaporin-2 (AQP2) trafficking. Several disorders, including hypertension and …

Lixivaptan, a new generation diuretic, counteracts vasopressin-induced aquaporin-2 trafficking and function in renal collecting duct cells

A Di Mise, M Venneri, M Ranieri, M Centrone… - International Journal of …, 2019 - mdpi.com
Vasopressin V2 receptor (V2R) antagonists (vaptans) are a new generation of diuretics.
Compared with classical diuretics, vaptans promote the excretion of retained body water in …

Activation of the calcium-sensing receptor corrects the impaired mitochondrial energy status observed in renal polycystin-1 knockdown cells modeling autosomal …

A Di Mise, M Ranieri, M Centrone, M Venneri… - Frontiers in Molecular …, 2018 - frontiersin.org
Autosomal Dominant Polycistic kidney Disease (ADPKD) is a renal channelopathy due to
loss-of-function mutations in the PKD1 or PKD2 genes, encoding polycystin-1 (PC1) or …

[HTML][HTML] Urinary aquaporin 2 as a potential indicator predicting tolvaptan response in patients with ADPKD

S Makabe, S Manabe, H Kataoka, T Akihisa… - Kidney International …, 2021 - Elsevier
Introduction Tolvaptan is used to treat autosomal dominant polycystic kidney disease
(ADPKD) because it inhibits binding of the antidiuretic hormone vasopressin to the …

Weight‐reducing, lipid‐lowering and antidiabetic activities of a novel arginine vasopressin analogue acting at the V1a and V1b receptors in high‐fat‐fed mice

S Mohan, PR Flatt, N Irwin… - Diabetes, Obesity and …, 2021 - Wiley Online Library
Aim To assess the beneficial metabolic effects of the nonapeptide hormone, arginine
vasopressin (AVP), on metabolism. Materials and Methods We exchanged amino acids at …

Cross-Species Insights into Autosomal Dominant Polycystic Kidney Disease: Provide an Alternative View on Research Advancement

J Luo, Y Zhang, S Jayaprakash, L Zhuang… - International Journal of …, 2024 - mdpi.com
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a prevalent hereditary disorder
that affects the kidneys, characterized by the development of an excessive number of fluid …